Skip to content

Clinical trials

Phase 3 Crohn Disease trials in France

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Crohn Disease Phase: Phase 3 Country / region: France Clear all

78 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20021
20031
20043
20052
20068
20071
20091
20102
20117
20123
20143
20154
20163
20177
20188
20193
20202
20213
20222
20231
20248
20253
20262

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed37
Terminated17
Recruiting14
Active, not recruiting8
Unknown status1
Withdrawn1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
AbbVie9
Janssen Research & Development, LLC9
Celgene7
Abbott5
Eli Lilly and Company4
GlaxoSmithKline4
Groupe d'Etude Therapeutique des Affections Inflammatoires Digestives3
Janssen-Cilag Ltd.3
Takeda3
UCB Pharma3

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Crohn Disease78
Inflammatory Bowel Diseases14
Colitis, Ulcerative5
Colitis3
Arthritis, Psoriatic2
Anemia1
Anemia, Iron-Deficiency1
Arthritis, Juvenile1
Colorectal Neoplasms1
Cytomegalovirus Infections1

Trials

Showing 1 to 25 of 78. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.